Literature DB >> 8927412

The reduced urinary output after spinal cord injury: a review.

J R Silver1, J R Doggart, R G Burr.   

Abstract

Oliguria in patients following spinal cord injury was first mentioned in 1649, but has since been referred to only occasionally. The work detailed here was completed 30 years ago but is reported because of the lack of any comparable study and because suitable patients are not now readily available. A total of 27 water load tests were carried out on 20 patients. The test included measurement of serum osmolality to confirm absorption of ingested water. Impaired response to the water load was obtained in 17 tests: 12/13 between 1 and 5 days after onset of the cord lesion and 5/14 more than 2 weeks after injury. The possibilities that oliguria was due to dehydration, failure to absorb ingested water, hypotension or renal failure are discounted. In the first few days after injury, oliguria may be due to release of antidiuretic hormone as part of the metabolic response to trauma. The impaired response seen later is discussed in relation to possible neural and hormonal mechanisms. There is a need for further study of factors influencing water excretion in tetraplegic and paraplegic patients.

Entities:  

Mesh:

Year:  1995        PMID: 8927412     DOI: 10.1038/sc.1995.151

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  3 in total

1.  Response to 'Hyponatremia in spinal cord injury patients: new insight into differentiating between the dilution and depletion forms'.

Authors:  J R Silver
Journal:  Spinal Cord       Date:  2015-07-28       Impact factor: 2.772

2.  Reply 'Hyponatremia in spinal cord injury patients: new insight into differentiating between the dilution and depletion forms'.

Authors:  J Kriz; O Schuck; M Horackova
Journal:  Spinal Cord       Date:  2015-07-28       Impact factor: 2.772

3.  Re: A study of predictors for hyponatraemia in patients with cervical spinal cord injury.

Authors:  J R Silver
Journal:  Spinal Cord       Date:  2018-03-20       Impact factor: 2.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.